Your browser is no longer supported. Please, upgrade your browser.
Settings
TMO [NYSE]
Thermo Fisher Scientific Inc.
IndexS&P 500 P/E30.10 EPS (ttm)21.55 Insider Own0.10% Shs Outstand394.00M Perf Week2.00%
Market Cap256.28B Forward P/E30.17 EPS next Y21.50 Insider Trans-26.80% Shs Float393.24M Perf Month4.63%
Income8.56B PEG2.55 EPS next Q6.42 Inst Own90.10% Short Float0.70% Perf Quarter16.16%
Sales39.06B P/S6.56 EPS this Y73.80% Inst Trans0.82% Short Ratio2.15 Perf Half Y45.14%
Book/sh98.25 P/B6.60 EPS next Y-8.24% ROA12.40% Target Price675.60 Perf Year43.09%
Cash/sh- P/C- EPS next 5Y11.80% ROE23.60% 52W Range433.52 - 666.65 Perf YTD39.29%
Dividend1.04 P/FCF34.00 EPS past 5Y26.50% ROI12.30% 52W High-2.68% Beta0.74
Dividend %0.16% Quick Ratio2.60 Sales past 5Y13.70% Gross Margin51.10% 52W Low49.65% ATR13.97
Employees80000 Current Ratio3.20 Sales Q/Q9.50% Oper. Margin27.00% RSI (14)67.69 Volatility2.45% 2.10%
OptionableYes Debt/Eq0.56 EPS Q/Q-1.10% Profit Margin21.90% Rel Volume1.45 Prev Close638.74
ShortableYes LT Debt/Eq0.56 EarningsOct 27 BMO Payout4.40% Avg Volume1.28M Price648.77
Recom1.80 SMA202.47% SMA506.73% SMA20024.26% Volume1,854,956 Change1.57%
Oct-20-21Upgrade Citigroup Neutral → Buy $620 → $700
Oct-15-21Resumed Cowen Outperform $655 → $696
Aug-05-21Resumed Credit Suisse Outperform $580
Jul-16-21Initiated The Benchmark Company Buy $580
Mar-18-21Upgrade KeyBanc Capital Markets Sector Weight → Overweight
Mar-03-21Initiated Barclays Overweight $525
Jan-08-21Upgrade Credit Suisse Neutral → Outperform $490 → $556
Dec-16-20Downgrade Citigroup Buy → Neutral $550 → $500
Dec-02-20Initiated Goldman Buy $570
Nov-10-20Initiated KeyBanc Capital Markets Sector Weight $550
Sep-30-20Initiated Atlantic Equities Overweight $494
Sep-14-20Initiated Morgan Stanley Overweight $485
Aug-20-20Resumed JP Morgan Overweight $460
Jul-15-20Upgrade Cleveland Research Neutral → Buy
Jul-07-20Reiterated Needham Buy $383 → $415
Apr-23-20Reiterated Needham Buy $341 → $383
Jan-31-20Reiterated Needham Buy $331 → $341
Jan-22-20Initiated Credit Suisse Neutral $341
Jan-08-20Initiated Wells Fargo Equal Weight $350
Jan-07-20Initiated Citigroup Buy $380
Nov-29-21 12:50PM  
11:55AM  
11:15AM  
01:00AM  
01:00AM  
Nov-26-21 02:21PM  
07:26AM  
Nov-25-21 07:55AM  
Nov-24-21 11:08AM  
09:40AM  
09:00AM  
Nov-23-21 11:08AM  
07:54AM  
Nov-22-21 08:42AM  
07:46AM  
07:40AM  
Nov-19-21 03:08PM  
08:29AM  
05:55AM  
Nov-18-21 10:31AM  
10:29AM  
09:11AM  
08:00AM  
Nov-17-21 10:34AM  
10:13AM  
09:26AM  
Nov-16-21 11:54AM  
11:30AM  
11:04AM  
11:02AM  
10:37AM  
07:57AM  
07:57AM  
Nov-15-21 10:52AM  
08:53AM  
08:52AM  
Nov-12-21 07:37PM  
11:00AM  
10:36AM  
10:23AM  
09:36AM  
08:33AM  
Nov-11-21 03:11PM  
10:48AM  
08:26AM  
Nov-10-21 11:58AM  
09:54AM  
09:29AM  
07:32AM  
Nov-09-21 04:10PM  
09:54AM  
07:33AM  
06:20AM  
Nov-08-21 12:45PM  
10:30AM  
10:18AM  
10:16AM  
09:29AM  
Nov-05-21 12:54PM  
11:12AM  
10:34AM  
10:32AM  
09:14AM  
07:50AM  
Nov-04-21 07:19PM  
10:46AM  
10:21AM  
09:59AM  
09:06AM  
09:05AM  
09:04AM  
08:14AM  
07:55AM  
07:44AM  
06:40AM  
Nov-03-21 04:07PM  
03:31PM  
12:51PM  
11:21AM  
11:07AM  
10:59AM  
10:26AM  
10:24AM  
09:48AM  
09:37AM  
09:36AM  
08:34AM  
Nov-02-21 12:51PM  
10:59AM  
10:51AM  
10:16AM  
09:22AM  
Nov-01-21 11:45AM  
09:12AM  
08:52AM  
12:40AM  
Oct-30-21 03:00PM  
Oct-29-21 01:03PM  
12:45PM  
10:39AM  
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Williamson StephenSr. VP and CFONov 02Option Exercise129.7722,5502,926,31462,771Nov 03 04:34 PM
Stevenson MarkExecutive Vice President & COONov 02Option Exercise175.4626,9254,724,37486,181Nov 03 04:36 PM
Williamson StephenSr. VP and CFONov 02Sale638.1022,55014,389,04540,221Nov 03 04:34 PM
Stevenson MarkExecutive Vice President & COONov 02Sale638.0326,92517,179,05459,256Nov 03 04:36 PM
Stevenson MarkExecutive Vice President & COONov 01Option Exercise175.4626,9254,724,37486,181Nov 03 04:36 PM
Stevenson MarkExecutive Vice President & COONov 01Sale632.6926,92517,035,09359,256Nov 03 04:36 PM
Holmes Joseph R.VP & Chief Accounting OfficerAug 09Option Exercise198.21759150,4401,372Aug 10 04:18 PM
Holmes Joseph R.VP & Chief Accounting OfficerAug 09Sale542.75759411,948897Aug 10 04:18 PM
CASPER MARC NChairman & CEOAug 05Sale539.9310,0005,399,345189,060Aug 06 04:29 PM
CASPER MARC NChairman & CEOAug 04Sale539.0510,0005,390,468199,060Aug 06 04:29 PM
CASPER MARC NChairman & CEOAug 03Sale535.7310,0005,357,276209,060Aug 04 04:25 PM
Stevenson MarkExecutive Vice President & COOAug 02Option Exercise175.4626,9254,724,37489,279Aug 04 04:22 PM
CASPER MARC NChairman & CEOAug 02Sale535.4610,0005,354,584219,060Aug 04 04:25 PM
Stevenson MarkExecutive Vice President & COOAug 02Sale535.3826,92514,415,22062,354Aug 04 04:22 PM
MANZI JIM PDirectorJul 30Sale536.54572306,89917,752Aug 02 04:05 PM
Lagarde MichelExecutive Vice PresidentMay 10Option Exercise190.5921,6004,116,74440,061May 11 04:44 PM
Lagarde MichelExecutive Vice PresidentMay 10Sale464.5121,60010,033,51818,461May 11 04:44 PM
Lagarde MichelExecutive Vice PresidentMay 07Option Exercise190.5929,1005,546,16952,629May 11 04:44 PM
Lagarde MichelExecutive Vice PresidentMay 07Sale472.6034,16816,147,63618,461May 11 04:44 PM
Lagarde MichelExecutive Vice PresidentFeb 12Sale507.797,2903,701,78915,775Feb 17 04:01 PM
Stevenson MarkExecutive Vice President & COODec 07Option Exercise129.7723,8253,091,77067,717Dec 08 04:31 PM
Stevenson MarkExecutive Vice President & COODec 07Sale473.8414,1336,696,78153,584Dec 08 04:31 PM
Stevenson MarkExecutive Vice President & COODec 04Option Exercise129.7723,8253,091,77058,005Dec 08 04:31 PM
Stevenson MarkExecutive Vice President & COODec 04Sale476.4614,1136,724,28043,892Dec 08 04:31 PM